Venrock Healthcare Capital Partners II, L.P. - Jul 18, 2022 Form 4 Insider Report for Tricida, Inc. (TCDA)

Role
10%+ Owner
Signature
/s/ David L. Stepp, Authorized Signatory
Stock symbol
TCDA
Transactions as of
Jul 18, 2022
Transactions value $
$1,377,250
Form type
4
Date filed
7/20/2022, 04:38 PM
Previous filing
Jul 14, 2022
Next filing
Jul 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCDA Common Stock Purchase $902K +100K +1.37% $9.02* 7.41M Jul 18, 2022 By Funds F1, F2, F3
transaction TCDA Common Stock Purchase $237K +25K +0.34% $9.47* 7.44M Jul 19, 2022 By Funds F3, F4, F5
transaction TCDA Common Stock Purchase $239K +25K +0.34% $9.54* 7.46M Jul 20, 2022 By Funds F3, F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of (i) 26,290 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 2,630 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (iii) 71,080 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.91 to $9.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F3 VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein.
F4 Consists of (i) 6,573 shares purchased by VHCP III, (ii) 657 shares purchased by VHCP Co-3 and (iii) 17,770 shares purchased by VHCP EG.
F5 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.12 to $9.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F6 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.18 to $10.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.